S E Aldridge

Summary

Affiliation: University of Newcastle
Country: UK

Publications

  1. pmc Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
    S E Aldridge
    The School of Surgical Sciences, The Medical School, Framlington Place, University of Newcastle upon Tyne, NE2 4HH, UK
    Br J Cancer 92:1531-7. 2005
  2. ncbi request reprint Vascular endothelial growth factor receptors in osteoclast differentiation and function
    S E Aldridge
    The School of Surgical Sciences, The Medical School, Framlington Place, University of Newcastle upon Tyne, NE2 4HH, UK
    Biochem Biophys Res Commun 335:793-8. 2005

Collaborators

Detail Information

Publications2

  1. pmc Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
    S E Aldridge
    The School of Surgical Sciences, The Medical School, Framlington Place, University of Newcastle upon Tyne, NE2 4HH, UK
    Br J Cancer 92:1531-7. 2005
    ..Consequently, VEGF signalling may be a therapeutic target for osteoclast inhibition in conditions such as tumour osteolysis...
  2. ncbi request reprint Vascular endothelial growth factor receptors in osteoclast differentiation and function
    S E Aldridge
    The School of Surgical Sciences, The Medical School, Framlington Place, University of Newcastle upon Tyne, NE2 4HH, UK
    Biochem Biophys Res Commun 335:793-8. 2005
    ..We have shown that VEGF induces osteoclast differentiation through its action on VEGFR1. The way in which VEGF mediates its effect on mature osteoclast activity, however, may be through its interaction with both receptor subtypes...